Journal
JOURNAL OF NEUROCHEMISTRY
Volume 107, Issue 2, Pages 533-543Publisher
WILEY
DOI: 10.1111/j.1471-4159.2008.05648.x
Keywords
chemoprevention; neurodegeneration; neuroprotection; oxidative stress; phase II enzymes; thioredoxin
Categories
Funding
- the Royal Society
- the Wellcome Trust
- the Biotechnology and Biological Sciences Research Council (BBSRC)
- BBSRC [BB/D011388/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/D011388/1] Funding Source: researchfish
Ask authors/readers for more resources
Peroxiredoxins are an important family of cysteine-based antioxidant enzymes that exert a neuroprotective effect in several models of neurodegeneration. However, under oxidative stress they are vulnerable to inactivation through hyperoxidation of their active site cysteine residues. We show that in cortical neurons, the chemopreventive inducer 3H-1,2-dithiole-3-thione (D3T), that activates the transcription factor Nuclear factor erythroid 2-related factor (Nrf2), inhibits the formation of inactivated, hyperoxidized peroxiredoxins following oxidative trauma, and protects neurons against oxidative stress. In both neurons and glia, Nrf2 expression and treatment with chemopreventive Nrf2 activators, including D3T and sulforaphane, up-regulates sulfiredoxin, an enzyme responsible for reducing hyperoxidized peroxiredoxins. Induction of sulfiredoxin expression is mediated by Nrf2, acting via a cis- acting antioxidant response element (ARE) in its promoter. The ARE element in Srxn1 contains an embedded activator protein-1 (AP-1) site which directs induction of Srxn1 by synaptic activity. Thus, raising Nrf2 activity in neurons prevents peroxiredoxin hyperoxidation and induces a new member of the ARE-gene family, whose enzymatic function of reducing hyperoxidized peroxiredoxins may contribute to the neuroprotective effects of Nrf2 activators.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available